On Thursday 07/18/2024 the closing price of the Healthsouth Corp Registered Shs share was $85.36 on BTT.
Compared to the opening price on Thursday 07/18/2024 on BTT of $85.64, this is a drop of 0.33%.
Healthsouth Corp Registered Shs's market capitalization is $8.60 B by 100.69 M shares outstanding.
Is Healthsouth stock a Buy, Sell or Hold?
Healthsouth stock has received a consensus rating of buy. The average rating score is and is based on 30 buy ratings, 8 hold ratings, and 0 sell ratings.What was the 52-week low for Healthsouth stock?
The low in the last 52 weeks of Healthsouth stock was 58.43. According to the current price, Healthsouth is 145.71% away from the 52-week low.What was the 52-week high for Healthsouth stock?
The high in the last 52 weeks of Healthsouth stock was 88.21. According to the current price, Healthsouth is 96.52% away from the 52-week high.What are analysts forecasts for Healthsouth stock?
The 38 analysts offering price forecasts for Healthsouth have a median target of 78.50, with a high estimate of 113.00 and a low estimate of 57.00. The median estimate represents a 108.46 difference from the last price of 85.14.Healthsouth Stock Snapshot
57.62
Bid
1.00
Bid Size
85.54
Ask
3.00
Ask Size
7/19/2024
Date
4:00 PM
Time
0.00
Volume
85.36
Prev. Close
0.00
Open
100.69 M
Number of Shares
58.43
52 Week Low
88.21
52 Week High
85.14
0.60
Dividend in USD
0.90
Dividend Yield
19.20
P/E Ratio
98.47
Free Float in %
3.51
EPS in USD
16.43
Book Value per Share in USD
8.40
Cash Flow per Share in USD
Healthsouth News More News
Historical Prices for Healthsouth
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Healthsouth Analyst Data
Total Analysts: 38
Analyst: {{ANALYST_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price-Target: {{PRICE_DATA}}
Rating: {{RATING_DATA}}
Price
*Price Target
Lowest: 57.00
Median: 78.50
Highest: 113.00
*The average price target includes all analyst analysis, not just the most recent analysis presented in the chart.
Healthsouth Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price | |||
---|---|---|---|---|---|---|
07/10/24 | Barclays Capital | Maintained Buy | $113 | |||
06/05/24 | Stephens Inc. | Maintained Buy | $94 | |||
05/22/24 | RBC Capital Markets | Maintained Buy | $95 | |||
04/26/24 | Raymond James Financial, Inc. | Maintained Buy | $95 | |||
04/25/24 | Barclays Capital | Maintained Buy | $108 | |||
04/25/24 | Mizuho | Maintained Buy | $95 | |||
03/28/24 | Barclays Capital | Maintained Buy | $101 | |||
03/06/24 | Barclays Capital | Maintained Buy | $95 | |||
02/09/24 | RBC Capital Markets | Maintained Buy | $83 | |||
02/09/24 | Mizuho | Maintained Buy | $82 | |||
01/16/24 | Stephens Inc. | Maintained Buy | $85 | |||
09/28/23 | RBC Capital Markets | Maintained Buy | CAD83 | |||
08/08/23 | RBC Capital Markets | Maintained Buy | $83 | |||
08/04/23 | Credit Suisse | Maintained Buy | $80 | |||
08/03/23 | Raymond James Financial, Inc. | Maintained Buy | $85 | |||
08/03/23 | Mizuho | Maintained Buy | $77 | |||
08/03/23 | Barclays Capital | Maintained Hold | $71 | |||
07/20/23 | Stephens Inc. | Maintained Buy | $78 | |||
06/29/23 | Stephens Inc. | Maintained Buy | $78 | |||
05/02/23 | RBC Capital Markets | Maintained Buy | $70 | |||
05/02/23 | Raymond James Financial, Inc. | Maintained Buy | $80 | |||
05/01/23 | Deutsche Bank | Maintained Buy | $73 | |||
05/01/23 | Stephens Inc. | Maintained Buy | $74 | |||
05/01/23 | Credit Suisse | Maintained Buy | $76 | |||
05/01/23 | Mizuho | Maintained Buy | $74 | |||
04/28/23 | Bank of America Merrill Lynch | Maintained Buy | $74 | |||
04/04/23 | Barclays Capital | Maintained Hold | $61 | |||
03/14/23 | Barclays Capital | Maintained Hold | $57 | |||
02/09/23 | Credit Suisse | Maintained Buy | $73 | |||
02/09/23 | Mizuho | Maintained Buy | $69 | |||
02/08/23 | Stephens Inc. | Maintained Buy | $70 | |||
10/28/22 | Stephens Inc. | Maintained Buy | $58 | |||
10/28/22 | Raymond James Financial, Inc. | Maintained Buy | $72 | |||
09/21/22 | Credit Suisse | Maintained Buy | $62 | |||
08/24/22 | RBC Capital Markets | Maintained Buy | $66 | |||
08/04/22 | BMO Capital Markets | Maintained Buy | $65 | |||
08/04/22 | Raymond James Financial, Inc. | Maintained Buy | $65 | |||
08/04/22 | Barclays Capital | Maintained Buy | $63 |
Healthsouth Estimates* in USD
2024 | 2025 | 2026 | 2027 | 2028 | |
---|---|---|---|---|---|
Revenue | 5,307 | 5,777 | 6,280 | 6,660 | 7,150 |
Dividend | 0.60 | 0.60 | 0.40 | - | - |
Dividend Yield (in %) | 0.70 % | 0.70 % | 0.47 % | - | - |
EPS | 4.11 | 4.59 | 5.08 | 4.94 | 5.19 |
P/E Ratio | 20.69 | 18.53 | 16.75 | 17.23 | 16.40 |
EBIT | 747 | 821 | 898 | 902 | 970 |
EBITDA | 1,055 | 1,147 | 1,252 | 1,278 | 1,357 |
Net Profit | 405 | 454 | 515 | 573 | 624 |
Net Profit Adjusted | 405 | 454 | 515 | 573 | 624 |
Pre-Tax Profit | 651 | 725 | 779 | 774 | 843 |
Net Profit (Adjusted) | 619 | 700 | 792 | - | - |
EPS (Non-GAAP) ex. SOE | 4.11 | 4.59 | 5.08 | 4.94 | 5.19 |
EPS (GAAP) | 4.27 | 4.75 | 5.21 | 4.94 | 5.19 |
Gross Income | - | - | - | - | - |
Cash Flow from Investing | -164 | -166 | -135 | -73 | -76 |
Cash Flow from Operations | 821 | 864 | 931 | 994 | 1,057 |
Cash Flow from Financing | -164 | -166 | -135 | -73 | -76 |
Cash Flow per Share | 8.03 | 8.92 | 9.33 | - | - |
Free Cash Flow | 333 | 356 | 400 | 241 | 267 |
Free Cash Flow per Share | 3.56 | 3.77 | 3.76 | 2.08 | 2.22 |
Book Value per Share | 23.94 | 28.91 | 34.55 | - | - |
Net Debt | 2,479 | 2,278 | 2,083 | 2,301 | 2,110 |
Research & Development Exp. | - | - | - | - | - |
Capital Expenditure | 578 | 601 | 678 | 753 | 790 |
Selling, General & Admin. Exp. | 2,930 | 3,150 | 3,406 | - | - |
Shareholder’s Equity | 2,269 | 2,679 | 3,261 | 3,371 | 3,975 |
Total Assets | 6,496 | 6,951 | 7,674 | 8,388 | 9,161 |
Previous Quarter ending 06/30/24 |
Current Quarter ending 09/30/24 |
Next Quarter ending 12/31/24 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 12 | 12 | 12 | 12 | 12 |
Average Estimate | 1.014 USD | 0.955 USD | 1.020 USD | 4.114 USD | 4.595 USD |
Year Ago | 0.913 USD | 0.857 USD | 0.880 USD | 3.514 USD | - |
Publish Date | 8/5/2024 | 10/23/2024 | 2/5/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | - | - | - | 11 | 11 |
Average Estimate | - | - | - | 5,307 USD | 5,777 USD |
Year Ago | - | - | - | 4,801 USD | - |
Publish Date | - | - | - | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales | 4,801.20 | 4,348.60 | 5,121.60 | 4,644.40 | 4,605.00 | 4,277.30 | 3,919.00 |
Change of sales in % | 10.41 | -15.09 | 10.27 | 0.86 | 7.66 | 9.14 | 7.49 |
Gross profit on sales | 933.50 | 784.50 | 1,003.80 | 803.30 | 939.50 | 901.80 | 821.10 |
Gross profit on sales change in % | 18.99 | -21.85 | 24.96 | -14.50 | 4.18 | 9.83 | 4.72 |
Operating income | 731.80 | 630.20 | 806.50 | 647.80 | 692.50 | 681.60 | 649.40 |
Operating income change in % | 16.12 | -21.86 | 24.50 | -6.45 | 1.60 | 4.96 | 0.09 |
Income before tax | 607.20 | 450.80 | 657.20 | 472.60 | 562.30 | 493.20 | 496.40 |
Income before tax change in % | 34.69 | -31.41 | 39.06 | -15.95 | 14.01 | -0.64 | 2.99 |
Income after tax | 349.60 | 269.80 | 410.40 | 283.20 | 357.40 | 291.40 | 255.50 |
Income after tax change in % | 29.58 | -34.26 | 44.92 | -20.76 | 22.65 | 14.05 | 3.53 |
Balance Sheet in Mio. USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Total liabilities | 3,805.20 | 3,774.60 | 4,465.70 | 4,444.30 | 4,148.00 | 3,356.30 | 3,248.20 |
Long-term liabilities per share | 31.41 | 32.06 | 37.36 | 37.49 | 34.76 | 27.13 | 27.78 |
Equity | 2,297.20 | 1,861.90 | 2,399.20 | 2,001.60 | 1,932.70 | 1,818.70 | 1,645.50 |
Equity change in % | 25.73 | -31.44 | 20.36 | 17.44 | 5.91 | 8.04 | 60.58 |
Balance sheet total | 6,102.40 | 5,636.50 | 6,864.90 | 6,445.90 | 6,080.70 | 5,175.00 | 4,893.70 |
Balance sheet total change in % | 8.27 | -17.89 | 6.50 | 6.01 | 17.50 | 5.75 | 4.52 |
Key Data in USD
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales per share | 47.40 | 43.31 | 51.11 | 46.54 | 46.33 | 42.86 | 39.47 |
P/E ratio (year end quote, basic EPS) | 19.20 | 22.16 | 15.86 | 29.04 | 19.20 | 21.07 | 18.37 |
P/E ratio (year end quote, diluted EPS) | 19.20 | 22.16 | 15.86 | 29.04 | 19.20 | 21.07 | 18.37 |
P/E ratio (year end quote) | 19.20 | 22.16 | 15.86 | 29.04 | 19.20 | 21.07 | 18.37 |
Dividend yield in % | 0.90 | 1.44 | 1.72 | 1.35 | 1.59 | 1.69 | 1.98 |
Equity ratio in % | 27.00 | 23.25 | 27.84 | 24.64 | 22.24 | 24.67 | 24.15 |
Debt ratio in % | 62.36 | 66.97 | 65.05 | 68.95 | 68.22 | 64.86 | 66.38 |
Healthsouth Insider Activity
Name | Date | shares traded | shares held | Price | type (sell/buy) | option |
---|---|---|---|---|---|---|
Reidy Christopher R | 07/15/2024 | 426.00 | 11,863.00 | 86.63 | Buy | No |
Christie Edward M III | 07/15/2024 | 334.00 | 4,122.00 | 86.80 | Buy | No |
Reidy Christopher R | 07/14/2024 | 16.00 | 11,437.00 | n/a | Buy | No |
Maryland Patricia Anne | 07/14/2024 | 24.00 | 13,244.00 | n/a | Buy | No |
Williams Terrance | 07/14/2024 | 24.00 | 13,598.00 | n/a | Buy | No |
SCHLICHTING NANCY M | 07/14/2024 | 35.00 | 19,624.00 | n/a | Buy | No |
KATZ LESLYE G | 07/14/2024 | 80.00 | 45,941.00 | n/a | Buy | No |
CARMICHAEL GREG D | 07/14/2024 | 24.00 | 17,074.00 | n/a | Buy | No |
O'Connor Kevin J. | 07/14/2024 | 13.00 | 8,401.00 | n/a | Buy | No |
HERMAN JOAN E | 07/14/2024 | 80.00 | 45,941.00 | n/a | Buy | No |
Christie Edward M III | 07/14/2024 | 6.00 | 3,788.00 | n/a | Buy | No |
Charbonneau Elissa Joy | 05/23/2024 | 10,000.00 | 18,594.06 | 85.02 | Sell | No |
Darby John Patrick | 05/05/2024 | 14,543.00 | 84,773.00 | 83.94 | Sell | No |
Darby John Patrick | 05/05/2024 | 14,543.00 | 99,316.00 | 29.06 | Buy | No |
CARMICHAEL GREG D | 05/02/2024 | 2,000.00 | 17,050.00 | 83.73 | Buy | No |
Maryland Patricia Anne | 05/01/2024 | 1,978.00 | 13,220.00 | n/a | Buy | No |
Williams Terrance | 05/01/2024 | 1,978.00 | 13,574.00 | n/a | Buy | No |
KATZ LESLYE G | 05/01/2024 | 1,978.00 | 45,861.00 | n/a | Buy | No |
Tarr Mark J | 04/29/2024 | 44,976.00 | 554,098.00 | 83.27 | Sell | No |
Tarr Mark J | 04/29/2024 | 19,460.00 | 573,558.00 | 35.83 | Buy | No |
Tarr Mark J | 04/29/2024 | 25,516.00 | 599,074.00 | 29.06 | Buy | No |
Reidy Christopher R | 04/15/2024 | 411.00 | 9,443.00 | 79.56 | Buy | No |
Christie Edward M III | 04/15/2024 | 314.00 | 1,804.00 | 79.65 | Buy | No |
CHIDSEY JOHN | 04/15/2024 | 234.00 | 162,826.00 | 79.52 | Buy | No |
Reidy Christopher R | 04/14/2024 | 13.00 | 9,032.00 | n/a | Buy | No |
Healthsouth Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | Healthsouth Corp Registered Shs | 0.60 | 0.90 | USD |
2022 | Healthsouth Corp Registered Shs | 0.86 | 1.44 | USD |
2021 | Healthsouth Corp Registered Shs | 1.12 | 1.72 | USD |
2020 | Healthsouth Corp Registered Shs | 1.12 | 1.35 | USD |
2019 | Healthsouth Corp Registered Shs | 1.10 | 1.59 | USD |
2018 | Healthsouth Corp Registered Shs | 1.04 | 1.69 | USD |
2017 | Healthsouth Corp Registered Shs | 0.98 | 1.98 | USD |
2016 | Healthsouth Corp Registered Shs | 0.94 | 2.28 | USD |
2015 | Healthsouth Corp Registered Shs | 0.88 | 2.53 | USD |
2014 | Healthsouth Corp Registered Shs | 0.78 | 2.03 | USD |
2013 | Healthsouth Corp Registered Shs | 0.36 | 1.08 | USD |
2012 | Healthsouth Corp Registered Shs | 0.00 | 0.00 | USD |
2011 | Healthsouth Corp Registered Shs | 0.00 | 0.00 | USD |
2010 | Healthsouth Corp Registered Shs | 0.00 | 0.00 | USD |
2009 | Healthsouth Corp Registered Shs | 0.00 | 0.00 | USD |
*Yield of the Respective Date
Healthsouth Corp Registered Shs Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 1.014 USD | Q2 2024 Earnings Release | 08/05/2024 |
Earnings Report | 0.955 USD | Q3 2024 Earnings Release | 10/23/2024 |
Earnings Report | 1.020 USD | Q4 2024 Earnings Release | 02/05/2025 |
Earnings Report | 1.216 USD | Q1 2025 Earnings Release | 04/23/2025 |
Earnings Report | 1.159 USD | Q2 2025 Earnings Release | 08/05/2025 |
Healthsouth Corp Registered Shs Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Annual General Meeting | - | Annual General Meeting | 05/02/2024 |
Healthsouth Profile
Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL. .
Moody’s Daily Credit Risk Score
Healthsouth Shareholder
Owner | in % |
---|---|
Freefloat | 98.47 |
The Vanguard Group, Inc. | 10.05 |
Vanguard Group, Inc. (Subfiler) | 9.96 |
Wellington Management Co. LLP | 8.16 |
Wellington Management Co. LLP (Wellington Breakout) | 7.35 |
BlackRock Fund Advisors | 5.24 |
William Blair Investment Management LLC | 5.18 |
William Blair Investment Management LLC | 4.05 |
Invesco Advisers, Inc. | 3.43 |
Vanguard Total Stock Market ETF | 3.15 |
iShares Core S&P Mid Cap ETF | 3.11 |
BlackRock Institutional Trust Co. NA | 3.04 |
State Street Corp. | 2.96 |
The Baupost Group LLC | 2.93 |
Vanguard Small Cap Index Fund | 2.51 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.